Home | AMCP.org

Expand Your Knowledge of Immune-Mediated Skin Conditions

From Jan. 24–Feb.2, AMCP will launch a live 2-part webinar series focusing on alopecia and atopic dermatitis. Earn CPE credit while diving deeper into these immune-mediated skin conditions.

Registration for AMCP 2023 Is Now Open!

Define the future of managed care pharmacy with us in San Antonio, Texas, from March 21–24.

Season's Greetings from Everyone at AMCP!

Thank you to all our members and friends for your continued support.

Not a Member? Learn More.

The practice of managed care pharmacy applies clinical and scientific evidence to support the appropriate use of medications to enhance patient and population health outcomes while optimizing the use of limited health care resources.

Learn More

AMCP is the professional association leading the way to help patients get the medications they need at a cost they can afford. AMCP’s diverse members leverage their specialized expertise in clinical evidence and economics to optimize medication benefit design and population health management so patients can access cost-effective and safe medications and other drug therapies.

Learn More

News

Letters, Statements & Analysis

AMCP Offers Comments on Essential Health Benefits

1/31/23

On Dec. 2, the Centers for Medicare and Medicaid Services (CMS) issued a Request for Information (RFI) on Essential Health Benefits (EHB). The RFI sought input on a proposed switch to the U.S. Pharmacopeia Drug Classification (USP DC) standard for defining the EHB prescription drug category. AMCP's comments, submitted on Jan. 31, urge CMS to refrain from switching to any alternative prescription drug classification standard.

Letters, Statements & Analysis

AMCP Responds to Notice of Benefit and Payment Parameters for 20...

1/30/23

On Dec. 21, the Department of Health and Human Services released a proposed rule titled "Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2024." On Jan. 30, AMCP submitted comments which oppose two issues from the proposed rule; continuing formulary tier limitations for standardized plan options and new limits on the number of non-standardized plan options that issues may offer through the federal Marketplace.

All News

Events

Webinars

TRODELVY® (sacituzumab govitecan-hziy): A Drug Investigated for ...

Wednesday, February 1, 2023, 2–3 pm ET

HR+/HER2- breast cancer accounts for the majority of all breast cancer cases. Women with HR+/HER2- metastatic breast cancer have poor prognosis, with a 5-year survival rate of 31.9%.

This webinar will discuss:
-Overview of the Disease State and Current Treatment Landscape
-Sacituzumab govitecan-hziy: Clinical Evidence & Data from the TROPiCS-02 study

This is a pre-approval information exchange (PIE) webinar with the objective of education for payers and access decision-makers.

Webinars

Innovations in Immune-Mediated Skin Conditions Webinar Series

Thursday, Feb. 2, 2023, 3–4pm ET

AMCP is producing a series of live, CPE accredited 1-hour webinars in January and February 2023 focusing on evidence-based guidance and real-world implications of the growing treatment landscape for immune-mediated skin conditions.

All Events

Featured Content

Blog

The PIE Act: A Case Study in the Importance of Persistence in Po...

1/23/23

In the world of health care innovation, speed matters. But when it comes to developing and deploying cutting-edge treatments and therapeutics safely, a cautious and methodical approach is vital as well. Safety matters as much as speed, but faster doesn’t always mean riskier. In her latest blog, AMCP CEO Susan Cantrell discusses the history of the Pre-approval Information Exchange (PIE) Act and how it will help patients.

AMCP Advisory Groups

12/5/22

AMCP brings together groups of key stakeholders, including managed care decision-makers, subject matter experts, and sponsors to form advisory groups that work collaboratively toward addressing challenges and opportunities for the managed care pharmacy community. 

Drug Product Pipeline Resources

12/3/21

AMCP and Apperture are proud to present the AMCP Drug Product Pipeline, the latest innovation in providing access and insight into the formulary decision-making process.

Blog

PIE Act Gains Bipartisan Momentum Ahead of End-of-Year Push

11/15/22

With Congress back to work after the midterm elections, AMCP remains focused on the critical window that remains to pass important pieces of health legislation this year. In this blog post, AMCP CEO Susan Cantrell provides an exciting update on our legislative priority, the Pre-Approval Information Exchange (PIE) Act.

Corporate Opportunities

Network with and become a thought leader for AMCP’s 8,000+ member base of managed care professionals, while using AMCP’s resource center to stay current with industry issues and better understand your audiences.

Explore Options